Pharmaceutical logistics in demand as war rattles supply chains
As fears of medicine shortages grow amid the war in the Middle East, pharmaceutical logistics help ensure steady shipments to hospitals, pharmacies, and other customers worldwide.
#EPA flags
#microplastics,
#pharmaceuticals as contaminants in
#drinkingwaterThe Safe Drinking Water Act requires the EPA to publish an updated version of its Contaminant Candidate List every five years. This is the sixth iteration of the list. Microplastics and pharmaceuticals appear in the draft of the upcoming list, alongside per- and polyfluoroalkyl substances, or
#PFAS, and dozens of other chemicals and microbes.
https://www.npr.org/2026/04/02/nx-s1-5771155/epa-microplastics-pharmaceuticals-drinking-water JPMorgan Reduces Stake in Indivior While Other Funds Increase Investments
📰 Original title: JPMorgan Chase & Co. Has $5.01 Million Holdings in Indivior PLC $INDV
🤖 IA: It's not clickbait ✅
👥 Usuarios: It's not clickbait ✅
View full AI summary: https://killbait.com/en/jpmorgan-reduces-stake-in-indivior-while-other-funds-increase-investments/?redirpost=a497c613-58da-4fc2-b833-61bebf3d2dba
#business #investments #stocks #pharmaceuticals
JPMorgan Reduces Stake in Indivior While Other Funds Increase Investments
JPMorgan Chase & Co. reduced its holdings in Indivior PLC by 47% during the third quarter, selling 183,798 shares and retaining 207,588 shares valued at approximately $5.01 million…
JPMorgan Reduces Stake in Indivior While Other Funds Increase Investments
📰 Original title: JPMorgan Chase & Co. Has $5.01 Million Holdings in Indivior PLC $INDV
🤖 IA: It's not clickbait ✅
👥 Usuarios: It's not clickbait ✅
View full AI summary: https://killbait.com/en/jpmorgan-reduces-stake-in-indivior-while-other-funds-increase-investments/?redirpost=a497c613-58da-4fc2-b833-61bebf3d2dba
#business #investments #stocks #pharmaceuticals
JPMorgan Reduces Stake in Indivior While Other Funds Increase Investments
JPMorgan Chase & Co. reduced its holdings in Indivior PLC by 47% during the third quarter, selling 183,798 shares and retaining 207,588 shares valued at approximately $5.01 million…
Trump unveils 100% tariff that could hit some patented drugs this year
President Donald Trump has signed an executive order that could slap long-threatened pharmaceutical tariffs of up to 100% on some patented drugs from companies that don’t reach deals with his administration in the coming months. Companies that have signed a “most favored nation” pricing deal and are actively building facilities in the U.S. to onshore production of patented pharmaceuticals and their ingredients will have a 0% tariff. For those that don’t have a pricing deal but are building such projects in the U.S., a 20% tariff will apply but increase to 100% in four years. Companies still have months to negotiate before the 100% tariffs kick in. Also Thursday, Trump rolled out an update on his 50% tariffs on imported steel, aluminum and copper.
Annika Kim Constantino and Angelica Peebles report, new tariffs could reshape US drug prices! The Trump administration is imposing up to 100% tariffs on imported pharmaceuticals to pressure companies to lower costs and reshore production. This aggressive trade move aims to secure the domestic drug supply and ensure access. Dive deeper into the potential impacts:
https://www.cnbc.com/2026/04/02/trump-pharmaceutical-tariffs-100percent.html #Pharmaceuticals #TradePolicy #DrugPrices#MafiaState
I’m all for lower drug prices, but this will hurt #patients most.
#Trump sets 100% #drug #tariffs on companies that haven’t lowered prices
Makers of patented #pharmaceuticals can escape the import tax by agreeing to join Trump’s “most favored nation” program to reduce US drug prices or by establishing new factories to serve the #US market….
#law #extortion #medicine #prescriptions #treatments #therapies #access #availability
https://www.washingtonpost.com/business/2026/04/02/tariffs-drugs-pharma-trump/
Trump sets 100% drug tariffs on companies that haven’t lowered prices
President Donald Trump took two actions Thursday to adjust his evolving tariff regime: a 100 percent tariff on some imported drugs and adjusting his levies on industrial metals.
What's Your Vulnerability?
Africa: Gilead Under Fire for Not Selling HIV Drug Lenacapavir to MSF: [allAfrica] Pharmaceutical company Gilead Sciences has come under mounting pressure after refusing to sell its breakthrough HIV prevention drug, lenacapavir, directly to Médecins Sans Frontières (MSF), despite repeated requests.
http://newsfeed.facilit8.network/TRqtQB #HIV #Lenacapavir #GileadSciences #MSF #Pharmaceuticals
The Japan Times
Benjamin Carr, Ph.D. 👨🏻💻🧬
KillBait News
KillBait
Global News | Breaking, Latest News and Video for Canada
BakersRelay
WYM Mod
Nonilex
Ivi Choc
Headlines Africa